ES2056059T3 - Un metodo para preparar cefadroxil monohidrato cristalino. - Google Patents

Un metodo para preparar cefadroxil monohidrato cristalino.

Info

Publication number
ES2056059T3
ES2056059T3 ES87119079T ES87119079T ES2056059T3 ES 2056059 T3 ES2056059 T3 ES 2056059T3 ES 87119079 T ES87119079 T ES 87119079T ES 87119079 T ES87119079 T ES 87119079T ES 2056059 T3 ES2056059 T3 ES 2056059T3
Authority
ES
Spain
Prior art keywords
cefadroxil
monohydrate
preparing crystalline
cephadroxyl
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87119079T
Other languages
English (en)
Inventor
Leonardo Marsili
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rifar SRL
Original Assignee
Rifar SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rifar SRL filed Critical Rifar SRL
Application granted granted Critical
Publication of ES2056059T3 publication Critical patent/ES2056059T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

EL INVENTO RELATA A UN METOD PARA PREPARAR MONOHIDRATO CEFADROXIL CRISTALINO. ACORDE A ESTE METODO UN SOLVENTE CEFADROXIL ES MORTERADO CON ALCOHOL ISOPROPILO QUE CONTIENE MENOS DE 6% A 18% W/W DE AGUA A UNA TEMPERATURA ENTE +45 C Y +55 C: EL MONOHIDRATO CEFADROXIL CRISTALINO ES AISLADO POR FILTRACION. ALGUNOS DE LOS SOLVENTES CEFADROXIL QUE PUEDEN SER USADOS SON NUEVOS: ELLOS ESTAN PREPARADOS PARA A/ADIR DIMETILACETAMIDE, N-METIL-2-PIRROLIDONE O MONOMETILFORMAMIDA A UNA SOLUCION ACUOSA DE CEFADROXIL EN UN PH ENTRE 5,5 Y 6.
ES87119079T 1987-08-03 1987-12-22 Un metodo para preparar cefadroxil monohidrato cristalino. Expired - Lifetime ES2056059T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/080,999 US4898938A (en) 1987-08-03 1987-08-03 Method for preparing crystalline cefadroxil monohydrate

Publications (1)

Publication Number Publication Date
ES2056059T3 true ES2056059T3 (es) 1994-10-01

Family

ID=22161022

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87119079T Expired - Lifetime ES2056059T3 (es) 1987-08-03 1987-12-22 Un metodo para preparar cefadroxil monohidrato cristalino.

Country Status (18)

Country Link
US (1) US4898938A (es)
EP (1) EP0302145B1 (es)
JP (1) JP2655664B2 (es)
KR (1) KR960002910B1 (es)
CN (1) CN1016607B (es)
AT (1) ATE105560T1 (es)
AU (1) AU597136B2 (es)
CA (1) CA1285554C (es)
DE (1) DE3789810T2 (es)
DK (1) DK680387A (es)
ES (1) ES2056059T3 (es)
FI (1) FI88043C (es)
NO (1) NO168425C (es)
PH (1) PH23648A (es)
PT (1) PT86526B (es)
RU (1) RU1804461C (es)
YU (1) YU44649B (es)
ZA (1) ZA879701B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2023560A6 (es) * 1989-07-10 1992-01-16 Gema Sa Procedimiento para la produccion de hidrato de cefradina y solvato de cefradina y dimetilformamida.
US5589593A (en) * 1991-11-11 1996-12-31 Biochimica Opos Spa Crystalline form of a cephalosporin antibiotic
IT1251999B (it) * 1991-11-11 1995-05-27 Opos Biochimica Srl Forma cristallina di un antibiotico cefalosporinico
WO2003092626A2 (en) * 2002-05-03 2003-11-13 Smithkline Beecham Pharmco Puerto Rico, Inc. Carvedilol pharmasolve solvate
US20040077849A1 (en) * 2002-10-16 2004-04-22 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefadroxil
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
CN1311830C (zh) * 2004-02-27 2007-04-25 石药集团中奇制药技术(石家庄)有限公司 头孢羟氨苄口腔崩解片及其制备方法
CN102351884B (zh) * 2006-05-19 2015-06-17 中化帝斯曼制药有限公司荷兰公司 一种用于结晶头孢羟氨苄的方法
CN102134250B (zh) * 2011-01-19 2013-03-13 天津大学 一种头孢羟氨苄单水合物的结晶方法及结晶
CN104447795B (zh) * 2014-11-28 2016-08-17 珠海金鸿药业股份有限公司 一种头孢羟氨苄化合物及其药物组合物
CN105534937B (zh) * 2015-12-30 2019-12-03 石药集团欧意药业有限公司 一种头孢羟氨苄片剂及其制备方法
CN106588953B (zh) * 2016-11-08 2018-11-27 山东罗欣药业集团恒欣药业有限公司 一种抗感染药物头孢羟氨苄晶型化合物及其组合物
CN106588954B (zh) * 2016-11-08 2018-11-27 山东罗欣药业集团恒欣药业有限公司 一种抗感染药物羟氨苄晶体化合物及其组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
US4160863A (en) * 1977-04-07 1979-07-10 Bristol-Myers Company Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid
GB8714180D0 (en) * 1987-06-17 1987-07-22 Rifar Srl Anhydrous crystalline cefadroxil
WO1988008320A1 (en) * 1987-04-24 1988-11-03 Invenmark Limited Puzzle

Also Published As

Publication number Publication date
FI881040A (fi) 1989-02-04
JP2655664B2 (ja) 1997-09-24
ATE105560T1 (de) 1994-05-15
AU8304587A (en) 1989-02-09
CN1016607B (zh) 1992-05-13
YU242787A (en) 1989-02-28
DE3789810D1 (de) 1994-06-16
DK680387D0 (da) 1987-12-22
JPS6442487A (en) 1989-02-14
EP0302145A3 (en) 1989-08-23
YU44649B (en) 1990-10-31
FI881040A0 (fi) 1988-03-07
NO880026D0 (no) 1988-01-05
EP0302145A2 (en) 1989-02-08
AU597136B2 (en) 1990-05-24
DE3789810T2 (de) 1994-08-18
ZA879701B (en) 1988-06-23
KR890003775A (ko) 1989-04-18
EP0302145B1 (en) 1994-05-11
KR960002910B1 (ko) 1996-02-28
NO168425B (no) 1991-11-11
DK680387A (da) 1989-02-04
FI88043C (fi) 1993-03-25
CN1031085A (zh) 1989-02-15
CA1285554C (en) 1991-07-02
NO168425C (no) 1992-02-19
FI88043B (fi) 1992-12-15
PT86526B (pt) 1994-10-31
NO880026L (no) 1989-02-06
RU1804461C (ru) 1993-03-23
PT86526A (pt) 1989-09-14
PH23648A (en) 1989-09-27
US4898938A (en) 1990-02-06

Similar Documents

Publication Publication Date Title
ES2056059T3 (es) Un metodo para preparar cefadroxil monohidrato cristalino.
ES557515A0 (es) Procedimiento para la obtencion de derivados del acido piridin-3-carboxilico
DK103982A (da) Beta-laktam-eddikesyrederivater og deres anvendelse samt fremgangsmaade til fremstilling deraf og af 1-azabicyklo(3.2.0)-hept-2-en-antibiotika
ES2051724T3 (es) Un metodo para la produccion de un cefadroxilo cristalino substancialmente anhidro.
ES2068812T3 (es) Cefadroxil cristalino y metodo para producirlo.
FI864970A (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
AR230451A1 (es) Procedimiento para preparar derivados del acido pirido(1,3-de)1,4-benzoxacin-6-carboxilico
ES508833A0 (es) Procedimientos para preparar derivados de acido cefaloesporanico.
ES513928A0 (es) Procedimiento para preparar olefinas polares.
JPS5350193A (en) Antibacterials

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 302145

Country of ref document: ES